When to See a Specialist About Xeroderma pigmentosum group F
By Dr. Kai Sharma, MD · · Genetic Medicine
Our Genetic Medicine team put together this overview of xeroderma pigmentosum group F for patients and families.
About this topic
Topic: xeroderma pigmentosum group F. A xeroderma pigmentosum characterized by milder symptoms and later onset of skin cancer that has_material_basis_in homozygous or compound heterozygous mutation in the ERCC4 gene on chromosome 16p13.
Related care
- antimyasthenic agent therapy
- calcium supplementation
- progestin modifying agent therapy
- chelator agent therapy
- haptoglobin measurement
This article is for general information and does not replace advice from your clinician.